The draft updated guidance on assessing and preventing falls in older people and people aged 50 and over at higher risk opens ...

Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) TA1006 12 September 2024 12 September 2024 Evinacumab for treating homozygous familial hypercholesterolaemia ...

Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) TA1006 12 September 2024 12 September 2024 Evinacumab for treating homozygous familial hypercholesterolaemia ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

For the first time, NICE has recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back. We're seeking ...

Demand for NHS Talking Therapies has reached an all-time high. The service received 1.82 million referrals in 2023/24. This is slightly higher than 2021/2022, and more than double the 884,000 received ...

All NICE products on people with learning disabilities. Includes any guidance and quality standards.

Delirium is a sudden change in a person’s mental state. It is a serious condition that is sometimes mistaken for dementia or, more rarely, depression. Unlike dementia, delirium develops quickly and is ...

Pressure ulcers can be serious and lead to life-threatening complications, such as blood poisoning and gangrene. However, taking some simple steps can reduce the chance of pressure ulcers developing.

For the first time, NICE has recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back. Today (1 ...

Roche (mycophenolate mofetil, rituximab) – confidentiality agreement not signed, not participating Sandoz (methotrexate, mycophenolate mofetil, rituximab) – confidentiality agreement not signed, not ...